[Abstract Only] Randomized Trial: Intraperitoneal Cefepime Monotherapy Noninferior to Cefazolin Plus Ceftazidime for Empirical Treatment of Peritoneal Dialysis-associated Peritonitis

Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial – American Journal of Kidney Diseases (link to abstract – $ for full-text)

Related Commentary on Twitter

Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial https://t.co/SNa7EvOqjR@pongpratpk @TNephro pic.twitter.com/AnakbnmEFo

— AJKD (@AJKDonline) July 23, 2019